Journal Information
Vol. 34. Issue 4.
Pages 174-176 (April 1998)
Vol. 34. Issue 4.
Pages 174-176 (April 1998)
Full text access
Situación actual de la quimioterapia neoadyuvante en el carcinoma broncogénico de células no pequeñas
Visits
3348
Servicio de Neumología. Hospital Universitari La Fe. Valencia
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
C.F. Mountain.
Revisions in the international system for staging lung cancer.
Chest, 111 (1997), pp. 1.710-1.717
[2.]
F.G. Pearson, N.C. Delarue, R. Ilves, T.R. Todd, J.D. Cooper.
Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.
J Thorac Cardiovasc Surg, 83 (1982), pp. 1-11
[3.]
H. Takita, A.C. Hollinshead, D.J. Rizzo, C.M. Kramer, T.Y. Chen, J.N. Bhayana, et al.
Treatment of inoperable lung carcinoma: a combined modality approach.
Ann Thorac Surg, 28 (1979), pp. 363-368
[4.]
S. Taylor, M. Trybula, P. Bonomi, et al.
Simultaneous cisplatin-fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer.
Ann Thorac Surg, 43 (1987), pp. 87-91
[5.]
L.P. Faber, C.F. Kittle, W.H. Warren, P.D. Bonomi, S.G. Taylor IV, S. Reddy, et al.
Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer.
Ann Thorac Surg, 47 (1989), pp. 669-677
[6.]
A. Skarin, Jochel, M. son, T. Sheldon, A. Malcolm, P. Oliynyk, R. Overholt, et al.
Neoadjuvant chemotherapy in marginally resectable stage III MO non-small cell lung cancer: long-term follow-up in 41 patients.
J Surg Oncol, 40 (1989), pp. 266-274
[7.]
P.L. Weiden, S. Piantadosi.
Preoperative chemoradiotherapy in stage III non-small cell lung cancer: a phase II studv of the Lung Cancer Study Group.
J Nat Cancer Inst, 83 (1991), pp. 266-272
[8.]
G.M. Strauss, J.E. Herndon, D.D. Sherman, D.J. Mathisen, R.W. Carey, N.C. Choi, et al.
Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: report of a cancer and leukemia group B phase II study.
J Clin Oncol, 10 (1992), pp. 1.237-1.244
[9.]
D.H. Kirn, T.J. Lynch, S.J. Mentzer, T.H. Lee, G.M. Straus, A.D. Elias, et al.
Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer: impact of preoperative chemotherapy on resectability and downstaging.
J Thorac Cardiovasc Surg, 106 (1993), pp. 696-702
[10.]
R. Burkes, R. Ginsberg, F. Shepherd, M.E. Blackstein, M.E. Goldber, P.F. Waters, et al.
Induction chemotherapy with mitomycin C, vindesien and cisplatin for stage 111 unresectable non-small cell lung cancer: results of the Toronto phase II trial.
J Clin Oncol, 10 (1992), pp. 580-586
[11.]
N. Martini, M.G. Kris, B.J. Flehinger, R.J. Gralla, M.S. Bains, M.E. Burt, et al.
Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.
Ann Thorac Surg, 55 (1993), pp. 1.365-1.373
[12.]
V.W. Rusch, K.S. Albain, J.J. Crowley, T.W. Rice, A.T. Turrisi, J.K. Weick, et al.
Surgical resection of stage IIIA and stage IIIB non-small cell lung cancer after concurrent induction chemotherapy. A Southwest Oncology Group trial.
J Thorac Cardiovasc Surg, 105 (1993), pp. 97-106
[13.]
D.J. Sugarbaker, J. Herndon, L.J. Kohman, M.G. Krasna, M.R. Green.
Results of Cancer and Leukemia Group B Protocol 8935: A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small cell lung cancer.
J Thorac Cardiovasc Surg, 109 (1995), pp. 473-485
[14.]
J. Aristu, J. Rebollo, R. Martínez-Monge, J.M. Aramendía, J.C. Viera, I. Azinovic, et al.
Cisplatin, mitomycin, and vindesine followed by intraoperative and postoperative radiotherapy for stage III non-small cell lung cancer: final results of a phase II study.
Am J Clin Oncol, 20 (1997), pp. 276-281
[15.]
J.A.B. Roth, F. Fosella, R. Komaki, M.B. Ryan, J.B. Putnam Jr., J.S. Lee.
A randomized trial comparing perioperative chemotherapy and surgery alone in resectable stage IIIA non-small cell lung cancer.
J Nat Cancer Inst, 86 (1994), pp. 673-680
[16.]
R. Rosell, J. Gómez-Codina, C. Camps, J. Maestre, J. Padilla, A. Cantó, et al.
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in patients with non-small cell lung cancer.
N Engí J Med, 330 (1994), pp. 153-158
[17.]
Non-Small Cell Lung Cancer Colloborative Group.
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials.
Br Med J, 311 (1995), pp. 899-909
[18.]
D. Ukena, M. Leutz, H. Huwer, H.J. Schäfers, G.W. Sybrecht.
Induction chemotherapy in locally advanced stage IIIA/IIIB non-small cell lung cancer (NSCLC): paclitaxel/carboplatin vs. Mitomycin C/ifosfamide/cisplatin (MlC)..
EurRespirJ, 10 (1997), pp. 154
[19.]
V.W. Rusch.
Resection of stage III non-small cell lung cancer following induction therapy.
World J Surg, 19 (1995), pp. 817-822
[20.]
S. El Rouby, A. Thomas, D. Costin, C.R. Rosenberg, M. Potmesil, R. Silber, et al.
p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is dependent of MDR1/MDR3 gene expression.
Blood, 82 (1993), pp. 3.452-3.459
[21.]
R. Rosell, A. Font, A. Pifarré, M. Canela, J. Maurel, A. Arellano, et al.
The role of induction (neoadjuvant) chemotherapy in stage IIIA NSCLC.
Chest, 109 (1996), pp. 102-106
[22.]
M. Tonato.
The role of neoadjuvant chemotherapy in NSCLC.
Chest, 109 (1996), pp. 93-95
[23.]
J.P. Van Meerbeeck, J.F. Vansteenkiste, P.E.Y. Van Schil, P. Weynants, G. Scagliotti, S. Darwish, et al.
Neoadjuvant chemotherapy followed by surgical resection or thoracic radiotherapy in stage IIIA-N2 non-small cell lung cancer: a multicentric randomized European experience.
Eur Respir J, 10 (1997), pp. 153
[24.]
T.A.W. Spiinter.
Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer.
Semin Oncol, 16 (1996), pp. 59-61
Copyright © 1998. Sociedad Española de Neumología y Cirugía Torácica